Blood eosinophils as a marker of eosinophilic exacerbations in COPD

Slides:

Advertisements

Similar presentations

COPD case finding by spirometry in high-risk customers of urban community pharmacies: A pilot study D. Castillo, R. Guayta, J. Giner, F. Burgos, C. Capdevila,

Advertisements

Association of heart diseases with COPD and restrictive lung function – Results from a population survey Berne Eriksson, Anne Lindberg, Hana Müllerova,

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)

Venezuela: violence, human rights, and health-care realities

Doxycycline for outpatient-treated acute exacerbations of COPD: a randomised double- blind placebo-controlled trial Patricia van Velzen, MD, Gerben ter.

Pharmacogenetics and future drug development and delivery

Identifying poor compliance with CPAP in obstructive sleep apnoea: A simple prediction equation using data after a two week trial Dipansu Ghosh, Victoria.

A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease Yoshihiro Kobashi,

Dizziness in older adults

R. Naseer, L.J. Buck, M. Small, M. Munavvar Respiratory Medicine CME

Volume 376, Issue 9734, Pages (July 2010)

Thank God for Richard Dawkins?

Simple versus complex COPD: implications for health-care management

Reasons for increase in pneumococcal bacteraemia

The commercial determinants of health

COPD and asthma: the emergency is clear, now is the time for action

Meta-analysis of randomised controlled trials

Volume 153, Issue 4, Pages (April 2018)

Volume 153, Issue 4, Pages (April 2018)

The Irish health-care system and austerity: sharing the pain

Author gender in The Lancet journals

COPD and asthma: the emergency is clear, now is the time for action

Tidal volume and non-invasive ventilation failure – Authors' reply

Intraoperative radiotherapy for early breast cancer

Volume 376, Issue 9734, Pages (July 2010)

David J Blackley, Cara N Halldin, A Scott Laney

Gareth L Ackland, Maurizio Cecconi, Rupert M Pearse

Precision Medicine Urgency

Vitamin D supplementation to prevent asthma exacerbations: a systematic review and meta-analysis of individual participant data David A Jolliffe, PhD,

Aspirin in the prevention of cancer – Author's reply

Mannose-binding lectin deficiency and disease severity in non-cystic fibrosis bronchiectasis: a prospective study Dr James D Chalmers, MBChB, Brian J.

Rising food insecurity in Europe

Blood transcriptional signatures for tuberculosis diagnosis: a glass half-empty perspective – Authors' reply Timothy E Sweeney, Purvesh Khatri The Lancet.

Nicholas D Walter, Randall Reves, J Lucian Davis

Breastfeeding in the 21st century

INSIGHT and NORDIL The Lancet

Chediak-Higashi syndrome: pathognomonic feature

Disease and stigma The Lancet Volume 354, (December 1999)

Incident diabetes in clinical trials of antihypertensive drugs

Meta-analysis of randomised controlled trials

HIV myths should not be resuscitated

Pharmacogenetic testing in the UK clinical setting

Minimum clinically important difference for the COPD Assessment Test: a prospective analysis Dr Samantha S C Kon, MBBS, Jane L Canavan, PhD, Sarah E.

Volume 362, Pages s6-s7 (December 2003)

Adrian Martineau The Lancet Respiratory Medicine

Confessions of a journal junkie

Volume 371, Issue 9627, Pages (May 2008)

Telling it like it isn't: truth and lies in a post-9/11 world

Vitamin D supplementation to prevent asthma exacerbations: a systematic review and meta-analysis of individual participant data David A Jolliffe, PhD,

In-vitro fertilisation and risk of multiple pregnancy

Thank God for Richard Dawkins?

Low-technology approaches

The future of medical journals in the western world

Volume 373, Issue 9672, Pages (April 2009)

Inhaled triple therapy in chronic obstructive pulmonary disease

Costs of eliminating HIV in South Africa have been underestimated

Steven A Narod The Lancet Volume 349, Issue 9068, (June 1997)

A remarkable report card on progress in COPD

Difficulties of surgery in the developing world: a personal view

Improving management of neonatal infections

Sputum culture conversion in new TB regimens

Partial restoration of pancreatic function in a child with cystic fibrosis Ciara Howlett, Nicola J Ronan, Muireann NiChroinin, David Mullane, Barry J.

Tapestry of life The Lancet Volume 375, Issue 9723, (April 2010)

Refining treatment choices for ADHD

Clinic attendance and disengagement of young adults with type 1 diabetes after transition of care from paediatric to adult services (TrACeD): a randomised,

Targeted Care for COPD.

Volume 349, Issue 9062, Pages (May 1997)

The dilemma of vaginal breech delivery worldwide

Fighting for health: meet the doctor-activists

Autism, maths, and sex: the special triangle

Presentation transcript:

Blood eosinophils as a marker of eosinophilic exacerbations in COPD Timm Greulich, Claus Franz Vogelmeier The Lancet Respiratory Medicine Volume 6, Issue 5, (May 2018) DOI: 10.1016/S2213-2600(18)30095-X Copyright © 2018 Elsevier Ltd Terms and Conditions

Figure Annual exacerbation rate by blood eosinophil count Blood eosinophil count is a predictor of the exacerbation rate and treatment effect of ICS. Blood eosinophils are a probable marker of eosinophilic exacerbations predicting the effect of ICS on eosinophilic exacerbations, whereas exacerbations of other causes remain unchanged in their rate when with or without ICS. Data are from post-hoc analyses of clinical trials. ICS=inhaled corticosteroid. The Lancet Respiratory Medicine 2018 6, DOI: (10.1016/S2213-2600(18)30095-X) Copyright © 2018 Elsevier Ltd Terms and Conditions